On Wednesday, Lifelock Inc (NYSE:LOCK)’s shares inclined 1.64% to $15.52.
Lifelock Inc (LOCK) declared a partnership that will focus on educating victims of domestic violence about the associated risks of identity theft.
LifeLock will work with Sojourner Center to raise awareness of the potential risks that victims of domestic violence may face and offer tools to educate them on how to better assist protect themselves.
The partnership is part of LifeLock’s ongoing consumer education efforts, which comprise partnering with community groups to assist protect potential victims of identity theft by providing them with information and protection tools.
LifeLock, Inc. provides identity theft protection services for consumers; and consumer risk administration services for enterprises in the United States. It protects consumer subscribers through monitoring identity-related events, such as new account openings and credit-related applications; and enterprise customers through delivering on-demand identity risk, identity authentication, and credit information about consumers.
Owens-Illinois Inc (NYSE:OI)’s shares dropped -0.20% to $24.40.
Owens-Illinois Inc (OI) declared that the company will take part in the 2015 Macquarie Global Metals, Mining and Materials Conference on Wednesday, June 10, 2015 in New York, NY.
Owens-Illinois, Inc., through its auxiliaries, manufactures and sells glass container products to food and beverage manufacturers primarily in Europe, North America, South America, and the Asia Pacific. It produces glass containers for alcoholic beverages, counting beer, flavored malt beverages, spirits, and wine.
At the end of Wednesday’s trade, Biocept Inc (NASDAQ:BIOC)‘s shares surged 1.20% to $3.38.
Biocept Inc (BIOC) declared that it has reached a clinical partnership with Sarah Cannon Research Institute (SCRI), the research arm of Sarah Cannon, the global cancer enterprise of Hospital Corporation of America. The partnership seeks to determine the clinical utility of detecting biomarkers present in circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) in blood samples for estrogen positive (ER+) breast cancer patients using Biocept’s OncoCEE™ technology.
Biocept offers a highly sensitive and quantitative blood-based method for the detection and monitoring of biomarkers, which can lead to physicians making better informed treatment decisions based on genomic information.
The partnership is designed to demonstrate the utility of Biocept’s liquid biopsy diagnostics to detect biomarker status in cancer patients, and for the assessment of tumor treatment response over time.
Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA tests utilizing a standard blood sample.
Castlight Health Inc (NYSE:CSLT), ended its Wednesday’s trading session with 0.77% gain, and closed at $9.11.
Castlight Health Inc (CSLT) declared Castlight Elevate™, the first solution that enables employees to research behavioral health services, make educated treatment choices, and start care all through a personalized platform. In addition, Castlight Elevate privately and securely identifies employee populations who are at-risk for mental health disorders, and delivers personalized recommendations for treatment resources.
Castlight Elevate is the newest extension of the Castlight Enterprise Healthcare Cloud (EHC), a platform and suite of cloud-based applications that enable employers to manage and optimize their investment in healthcare benefits and empower employees to improve their healthcare decisions. Castlight Elevate leverages the breadth of the EHC platform capabilities, which are necessary for an organization to implement a comprehensive enterprise healthcare administration strategy.
Castlight Elevate breaks down the barriers to behavioral health treatment by targeting and engaging employees to take advantage of personalized treatment options and services. For example, an employee who may be struggling with depression can search for information about the condition, identify and compare therapists within their individual benefits network, and even start teletherapy right from his or her computer or mobile device.
Castlight Health, Inc. provides cloud-based software in the United States. Its software enables enterprises to understand and manage health care spending. It offers Enterprise Healthcare Cloud that transforms external and internal complex data into transparent and useful information.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
